Pfizer says new trial confirms high efficacy of its COVID antiviral pills
CBSN
Pfizer announced new results on Tuesday from studies testing its five-day course of COVID antiviral pills, confirming Paxlovid cut the risk of hospitalization or death in a trial for patients at high-risk of severe COVID-19 by 89% when treated within the first three days of their symptoms.
Pfizer also announced an interim analysis of data from another trial that found a 70% reduction in the risk of hospitalization and no deaths compared to placebo, in a study that also included unvaccinated adults who did not have underlying conditions putting them at high-risk of severe COVID-19.
The company says early results from its lab tests shows its antiviral will likely remain effective against all variants of concern, including Omicron.
Scientists say they've discovered the world's biggest coral, so huge it was mistaken for a shipwreck
Scientists say they have found the world's largest coral near the Pacific's Solomon Islands, announcing Thursday a major discovery "pulsing with life and color." The coral is so immense that researchers sailing the crystal waters of the Solomon archipelago initially thought they'd stumbled across a hulking shipwreck.